Status:
COMPLETED
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institutes of Health (NIH)
Trinity Health Of New England
Conditions:
Diabetes
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to co-develop a toolkit (known as the QBSAfe toolkit) with patients, family caregivers, and clinicians that focuses on palliating symptoms, alleviating burden of treatment...
Eligibility Criteria
Inclusion
- Existing diagnosis of diabetes mellitus; have an existing appointment with a participating clinician
Exclusion
- Do not speak English
- Severe vision/hearing impairment
- Unable to give informed consent for any reason
Key Trial Info
Start Date :
April 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 22 2020
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04514523
Start Date
April 28 2020
End Date
September 22 2020
Last Update
January 6 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06520
2
Trinity Health of New England
Waterbury, Connecticut, United States, 06706
3
Mayo Clinic
Rochester, Minnesota, United States, 55905